Rigel Pharmaceuticals
RIGL
#6932
Rank
A$0.97 B
Marketcap
A$52.81
Share price
-2.59%
Change (1 day)
73.87%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): A$0.19 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of A$0.18 Billion, an increase over its 2024 earnings that were of A$37.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.19 B4.75%
2025 A$0.18 B391.35%
2024 A$37.7 M-244.27%
2023 -A$26.14 Million-66.79%
2022 -A$78.7 Million340.73%
2021 -A$17.86 Million-56.15%
2020 -A$40.73 Million-57.34%
2019 -A$95.48 Million-7.66%
2018 -A$0.11 Billion-9.47%
2017 -A$0.12 Billion24.46%
2016 -A$91.76 Million23.63%
2015 -A$74.23 Million-43.29%
2014 -A$0.14 Billion2.5%
2013 -A$0.13 Billion
2010 A$54.3 M-133.97%
2009 -A$0.16 Billion-18.49%
2008 -A$0.2 Billion71.91%
2007 -A$0.12 Billion84.74%
2006 -A$61.75 Million-10.17%
2005 -A$68.74 Million-15.73%
2004 -A$81.58 Million39.29%
2003 -A$58.57 Million10.3%
2002 -A$53.1 Million48.3%
2001 -A$35.81 Million-2.13%
2000 -A$36.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$13.03 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$21.03 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-A$0.16 Billion-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-A$0.19 Billion-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA